id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0103-0025,FDA,FDA-2011-N-0103,Reference 6 Specific Identification of Bacillus anthracis,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:03Z,,0,0,0900006483b53a23
FDA-2011-N-0103-0023,FDA,FDA-2011-N-0103,Reference 8 Phage Isolated from Lysogenic Bacillus anthracis,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:01Z,,0,0,0900006483b53a25
FDA-2011-N-0103-0028,FDA,FDA-2011-N-0103,Reference 3 Regulatory Flexibility Analysis,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:05Z,,0,0,0900006483b53976
FDA-2011-N-0103-0026,FDA,FDA-2011-N-0103,Reference 5 Production and Validation of the Use of Gamma Phage,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:04Z,,0,0,0900006483b53978
FDA-2011-N-0103-0027,FDA,FDA-2011-N-0103,Reference 4 Abshire T.G. et at Validation ofthe use of gamma phage for identifying Bacillus anthracis,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:04Z,,0,0,0900006483b53977
FDA-2011-N-0103-0024,FDA,FDA-2011-N-0103,Reference 7 Differential Diagnosis of Bacillus cereus,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:02Z,,0,0,0900006483b53a24
FDA-2011-N-0103-0030,FDA,FDA-2011-N-0103,Reference 1 Class II Special Controls Guideline,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:06Z,,0,0,0900006483b53974
FDA-2011-N-0103-0031,FDA,FDA-2011-N-0103,Index to References FR,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:07Z,,0,0,0900006483b53d58
FDA-2011-N-0103-0029,FDA,FDA-2011-N-0103,Reference 2 Transcript of the FDA Microbiology Devices Panel Meeting March 7 2002,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:06Z,,0,0,0900006483b53975
FDA-2011-N-0103-0021,FDA,FDA-2011-N-0103,Microbiology Devices; Classification of In Vitro Diagnostic Devices for Bacillus Species Detection,Rule,Final Rule,2019-04-01T04:00:00Z,2019,4,2019-04-01T04:00:00Z,,2019-04-01T15:56:15Z,2019-06026,0,0,0900006483b512a0
FDA-2011-N-0103-0022,FDA,FDA-2011-N-0103,Reference 9 A colour Atlas of Bacillus Species,Supporting & Related Material,Background Material,2019-04-01T04:00:00Z,2019,4,,,2019-04-01T16:17:00Z,,0,0,0900006483b53a26